Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
J. Roujeau, R. Stern.
Severe adverse cutaneous reactions to drugs..
N Engl J Med, 331 (1994), pp. 1272-1285
[2.]
I. GarcÍa-Doval, L. LeCleach, H. Bocquet, X. Otero, J. Roujeau.
Toxic epidermal necrolisis and Steven-Johnson syndrome..
Arch Dermatol, 136 (2000), pp. 323-327
[3.]
I. Viard, P. Wehrli, R. Bullani, P. Schneider, N. Holler, D. Salomon, et al.
Inhibition of toxic epidermal necrolisis by blockade of CD95 with human intravenous immunoglobulin..
Science, 282 (1998), pp. 490-493
[4.]
S. Magina, C. Lisboa, E. Goncalves, F. Conceicao, V. Leal, J. Mesquita.
A case of toxic epidermal necrolysis treated with intravenous immunoglobulin..
Br J Dermatol, 142 (2000), pp. 177-199
[5.]
G. Lipper, K. Arndt, J. Dover.
Recent therapeutic advances in dermatology..
Jama, 283 (2000), pp. 175-177
[6.]
L. Leyva, M.J. Torres, S. Posadas, M. Blanca, G. Besso, F. O'Valle, et al.
Anticonvulsant-induced toxic epidermal necrolisys: Monitoring the immunologic response..
J Allergy Clin Immunol, 105 (2000), pp. 157-165
[7.]
R. Stern.
Improving the outcome of patients with toxic epidermal necrolysis and Stevens-Johnson Syndrome..
Arch Dermatol, 136 (2000), pp. 410-411
[8.]
J. Arevalo, J. Lorente, C. Gonzalez-Herrada, R. Jimenez.
Treatment of toxic epidermal necrolysis with Cyclosporin A..
J Trauma Inj Infect Critical Care, 48 (2000), pp. 473-478
Copyright © 2002. Asociación Española de Pediatría
